Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Fisher

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Disaster Medicine and Public Health Preparedness|June 16, 2025
The Incident Management Measurement Tool (IMMT): A Tool for Measuring Public Health Incident Management During and After EmergenciesVanessa Parks, Aaron Clark-Ginsberg, Jalal Awan, et al.
European Urology Open Science|March 4, 2022
Multidrug-resistant Uro-associated <i>Escherichia coli</i> Populations and Recurrent Urinary Tract Infections in Patients Performing Clean Intermittent Self-catheterisationCatherine Mowbray, Aaron Tan, Maxime Vallée, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United KingdomVinod S Hegade, George F Mells, Holly Fisher, et al.
Magnetic Resonance in Medicine|January 28, 2021
Reproducibility of <sup>19</sup> F-MR ventilation imaging in healthy volunteersBenjamin J Pippard, Mary A Neal, Adam M Maunder, et al.
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Health Technology Assessment (Winchester, England)|December 9, 2022
Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCTMichael Nugent, Valerie Bryant, Chrissie Butcher, et al.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Health Technology Assessment (Winchester, England)|May 17, 2018
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCTRobert Pickard, Thomas Chadwick, Yemi Oluboyede, et al.
BMJ Open|March 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acidSarah Dunn, Lysbeth Evans, Ciara Kennedy, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Disaster Medicine and Public Health Preparedness|June 16, 2025
The Incident Management Measurement Tool (IMMT): A Tool for Measuring Public Health Incident Management During and After EmergenciesVanessa Parks, Aaron Clark-Ginsberg, Jalal Awan, et al.
European Urology Open Science|March 4, 2022
Multidrug-resistant Uro-associated <i>Escherichia coli</i> Populations and Recurrent Urinary Tract Infections in Patients Performing Clean Intermittent Self-catheterisationCatherine Mowbray, Aaron Tan, Maxime Vallée, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United KingdomVinod S Hegade, George F Mells, Holly Fisher, et al.
Magnetic Resonance in Medicine|January 28, 2021
Reproducibility of <sup>19</sup> F-MR ventilation imaging in healthy volunteersBenjamin J Pippard, Mary A Neal, Adam M Maunder, et al.
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Health Technology Assessment (Winchester, England)|December 9, 2022
Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCTMichael Nugent, Valerie Bryant, Chrissie Butcher, et al.
The Lancet. Infectious Diseases|July 25, 2018
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trialHolly Fisher, Yemi Oluboyede, Thomas Chadwick, et al.
Health Technology Assessment (Winchester, England)|May 17, 2018
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCTRobert Pickard, Thomas Chadwick, Yemi Oluboyede, et al.
BMJ Open|March 11, 2026
Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acidSarah Dunn, Lysbeth Evans, Ciara Kennedy, et al.
Pageof 3